Buscar
Mostrando ítems 61-70 de 2370
Actualización en el diagnóstico y manejo del daño hepático agudo grave en el embarazo
(Sociedad Médica de Santiago, 2015)
Abnormalities in liver function tests appear in 3% of pregnancies. Severe
acute liver damage can be an exclusive condition of pregnancy (dependent or
independent of pre-eclampsia) or a concomitant disease. HELLP syndrome ...
Molecular pathways of nonalcoholic fatty liver disease development and progression
(Springer, 2019-01)
Nonalcoholic fatty liver disease (NAFLD) is a main hepatic manifestation of metabolic syndrome. It represents a wide spectrum of histopathological abnormalities ranging from simple steatosis to nonalcoholic steatohepatitis ...
Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice
(ELSEVIER ESPANA, 2021)
Introduction and Objectives: Nonalcoholic-fatty-liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome (MetS). Mineralocorticoid receptor (MR) activation is associated with increased risk of ...
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease Atherosclerosis As a Major Player in the Natural Course of NAFLD
(Bentham Science Publishers, 2013-02)
Non-alcoholic fatty liver disease (NAFLD) encompasses pure steatosis through nonalcoholic steatohepatitis (NASH) and is the most common cause of chronic liver disease in Western countries. NASH is a progressive liver disease ...
Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases
(NATURE PUBLISHING GROUP, 2010)
Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content
(SOCIEDAD LATINOAMERICANA DE NUTRICION, 2013)